https://scholars.lib.ntu.edu.tw/handle/123456789/552302
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | JANN-YUAN WANG | en_US |
dc.contributor.author | LI-NA LEE | en_US |
dc.contributor.author | HSIN-CHIH LAI | en_US |
dc.contributor.author | Hsu H.-L. | en_US |
dc.contributor.author | Liaw Y.-S. | en_US |
dc.contributor.author | PO-REN HSUEH | en_US |
dc.contributor.author | PAN-CHYR YANG | en_US |
dc.creator | Wang J.-Y.;Li-Na Lee;Lai H.-C.;Hsu H.-L.;Liaw Y.-S.;Hsueh P.-R.;Yang P.-C. | - |
dc.date.accessioned | 2021-03-12T02:28:49Z | - |
dc.date.available | 2021-03-12T02:28:49Z | - |
dc.date.issued | 2007 | - |
dc.identifier.issn | 0022-1899 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/552302 | - |
dc.description.abstract | Background. Reinfection is a major contributor to tuberculosis (TB). It seems that the higher the local incidence, the higher the proportion of reinfection. Methods. Based on a systematic review of the literature, we established a regression model to predict the reinfection proportion from the local incidence. We then used our local data to verify the algorithm. Results. Of the 23 studies addressing reinfection in recurrent TB, 6 were population based. The reinfection proportion was correlated with the local incidence (reinfection proportion = -29.7 + 36.8 X logIncidence) (95% confidence interval [CI] for coefficient, 15.3-58.3; R2 = 0.849). The reinfection proportion in Taiwan (incidence, 62.4/ 100,000 people) was estimated to be 36% (95% CI, 3%-69%). Of our 49 recurrent patients, 51% had reinfection. Patients with reactivation seemed more likely to have underlying diseases and less likely to be smear positive. The relapse isolates seemed more resistant than the initial isolates. Conclusions. The regression model could possibly predict the TB reinfection proportion from the local incidence. This algorithm is probably helpful in policy making for TB control programs. In areas where TB is endemic, reinfection might be responsible for >50% of TB cases, and aggressive surveillance to detect asymptomatic carriers could be an important strategy for controlling the disease. ? 2007 by the Infectious Diseases Society of America. All rights reserved. | - |
dc.relation.ispartof | Journal of Infectious Diseases | - |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | bacterial DNA; BCG vaccine; isoniazid; rifampicin; tuberculostatic agent; adult; aged; algorithm; article; bacterium culture; bacterium isolate; comorbidity; DNA fingerprinting; female; human; Human immunodeficiency virus infected patient; infection rate; major clinical study; male; multidrug resistance; Mycobacterium tuberculosis; nonhuman; prediction; priority journal; regression analysis; reinfection; statistical model; systematic review; Taiwan; tuberculosis; DNA Fingerprinting; Forecasting; Humans; Incidence; Models, Statistical; Recurrence; Regression Analysis; Tuberculosis | - |
dc.title | Prediction of the tuberculosis reinfection proportion from the local incidence | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1086/518898 | - |
dc.identifier.pmid | 17570116 | - |
dc.identifier.scopus | 2-s2.0-34447250283 | - |
dc.relation.pages | 281-288 | - |
dc.relation.journalvolume | 196 | - |
dc.relation.journalissue | 2 | - |
item.openairetype | journal article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
item.grantfulltext | none | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine-NTUHHC | - |
crisitem.author.dept | Laboratory Medicine | - |
crisitem.author.dept | Laboratory Medicine-NTUH | - |
crisitem.author.dept | Clinical Laboratory Sciences and Medical Biotechnology | - |
crisitem.author.dept | Laboratory Medicine | - |
crisitem.author.dept | Laboratory Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.dept | Clinical Medicine | - |
crisitem.author.dept | Clinical Pharmacy | - |
crisitem.author.dept | Oncology | - |
crisitem.author.dept | Biomedical Electronics and Bioinformatics | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.orcid | 0000-0003-3406-366X | - |
crisitem.author.orcid | 0000-0002-7654-2450 | - |
crisitem.author.orcid | 0000-0002-0605-5040 | - |
crisitem.author.orcid | 0000-0002-7502-9225 | - |
crisitem.author.orcid | 0000-0001-6330-6048 | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | NTU Hsin-Chu Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | College of Electrical Engineering and Computer Science | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。